Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 27% ± 4% | |
glutamatergic neuron | 3 studies | 34% ± 7% | |
endothelial cell of lymphatic vessel | 3 studies | 21% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2088.04 | 1445 / 1445 | 100% | 31.15 | 183 / 183 |
prostate | 100% | 2273.89 | 245 / 245 | 100% | 30.06 | 502 / 502 |
skin | 100% | 3006.09 | 1809 / 1809 | 100% | 44.09 | 472 / 472 |
stomach | 100% | 2943.00 | 359 / 359 | 100% | 28.47 | 286 / 286 |
breast | 100% | 2461.16 | 459 / 459 | 100% | 28.58 | 1117 / 1118 |
intestine | 100% | 2213.38 | 966 / 966 | 100% | 26.43 | 526 / 527 |
bladder | 100% | 2210.67 | 21 / 21 | 100% | 20.53 | 502 / 504 |
thymus | 100% | 2748.80 | 653 / 653 | 100% | 22.81 | 602 / 605 |
pancreas | 100% | 1349.06 | 328 / 328 | 99% | 19.93 | 177 / 178 |
lung | 100% | 1907.65 | 576 / 578 | 100% | 22.02 | 1151 / 1155 |
brain | 99% | 1494.56 | 2619 / 2642 | 100% | 29.00 | 705 / 705 |
uterus | 100% | 2190.54 | 170 / 170 | 99% | 18.31 | 455 / 459 |
kidney | 100% | 1635.10 | 89 / 89 | 99% | 21.17 | 893 / 901 |
ovary | 100% | 1841.13 | 180 / 180 | 99% | 18.02 | 426 / 430 |
adrenal gland | 100% | 2231.93 | 258 / 258 | 94% | 13.71 | 216 / 230 |
liver | 100% | 760.21 | 225 / 226 | 79% | 7.81 | 322 / 406 |
adipose | 100% | 2460.87 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2221.42 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 46.92 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.97 | 29 / 29 |
muscle | 100% | 1917.74 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2377.34 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 20.40 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 17.36 | 1 / 1 |
heart | 95% | 973.91 | 822 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 83% | 1497.38 | 769 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_0035542 | Biological process | regulation of SNARE complex assembly |
GO_0006914 | Biological process | autophagy |
GO_0006886 | Biological process | intracellular protein transport |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_0008333 | Biological process | endosome to lysosome transport |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0034058 | Biological process | endosomal vesicle fusion |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0033263 | Cellular component | CORVET complex |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005769 | Cellular component | early endosome |
GO_0005160 | Molecular function | transforming growth factor beta receptor binding |
GO_0046332 | Molecular function | SMAD binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TGFBRAP1 |
Protein name | Transforming growth factor-beta receptor-associated protein 1 (TGF-beta receptor-associated protein 1) (TRAP-1) (TRAP1) |
Synonyms | |
Description | FUNCTION: Plays a role in the TGF-beta/activin signaling pathway. It associates with inactive heteromeric TGF-beta and activin receptor complexes, mainly through the type II receptor, and is released upon activation of signaling. May recruit SMAD4 to the vicinity of the receptor complex and facilitate its interaction with receptor-regulated Smads, such as SMAD2. .; FUNCTION: Plays a role in vesicle-mediated protein trafficking of the endocytic membrane transport pathway. Believed to act as a component of the putative CORVET endosomal tethering complexes which is proposed to be involved in the Rab5-to-Rab7 endosome conversion probably implicating MON1A/B, and via binding SNAREs and SNARE complexes to mediate tethering and docking events during SNARE-mediated membrane fusion. The CORVET complex is proposed to function as a Rab5 effector to mediate early endosome fusion probably in specific endosome subpopulations . Functions predominantly in APPL1-containing endosomes and in degradative but not recycling trafficking of endocytosed cargo . . |
Accessions | Q8WUH2 ENST00000595531.5 ENST00000393359.7 |